Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
viridi's Profile
Displaying 101-150 of 258 result(s).
CYDY CytoDyn Inc
02/06/2021 12:39:16 AM
“and me.” Yes, I sincerely appr (2)
CYDY CytoDyn Inc
02/03/2021 5:52:17 PM
CGC; As a Kaiser member myself I wo (1)
CYDY CytoDyn Inc
02/01/2021 11:26:33 AM
My condolences Invisioner. The loss (3)
CYDY CytoDyn Inc
02/01/2021 11:21:18 AM
He isn’t gone, he gets the attent (2)
CYDY CytoDyn Inc
01/21/2021 8:45:59 PM
This long acting injectable will ta (4)
CYDY CytoDyn Inc
01/21/2021 6:01:32 PM
Arno, that pr is not from the fda,
CYDY CytoDyn Inc
01/21/2021 11:23:08 AM
That FDA PR was issued back in Nove
CYDY CytoDyn Inc
01/17/2021 7:51:34 PM
here is the link: https://www.faceb
CYDY CytoDyn Inc
01/17/2021 7:45:19 PM
Scott Carr's facebook post continue (5)
CYDY CytoDyn Inc
01/17/2021 7:43:16 PM
CDiddy; here is Scott Carr's post f (2)
CYDY CytoDyn Inc
01/14/2021 8:08:57 PM
Was #3) “Shorting the stock does (3)
CYDY CytoDyn Inc
01/14/2021 2:25:49 PM
I seem to recall Shelly had been in
CYDY CytoDyn Inc
01/13/2021 11:40:40 AM
There is a very good analysis of se (5)
CYDY CytoDyn Inc
01/01/2021 6:57:44 PM
I agree with you Chazz, and will ad (4)
CYDY CytoDyn Inc
01/01/2021 3:31:16 PM
I appreciate your ability to refocu (2)
CYDY CytoDyn Inc
01/01/2021 1:08:44 PM
The problem is that Gates has limit (5)
CYDY CytoDyn Inc
12/22/2020 12:21:41 AM
The optics of this don’t look goo
CYDY CytoDyn Inc
12/21/2020 8:11:24 PM
“I would like to see the price of (1)
CYDY CytoDyn Inc
12/21/2020 7:40:42 PM
It looks like another strain in Sou
CYDY CytoDyn Inc
12/19/2020 12:11:10 PM
Don’t shoot the messenger here - (2)
CYDY CytoDyn Inc
12/18/2020 8:41:10 PM
This discussion falls into my gener (6)
CYDY CytoDyn Inc
12/18/2020 8:03:14 PM
I understand your argument - the qu
CYDY CytoDyn Inc
12/18/2020 7:30:27 PM
“ why is 300,000 doses of drug on (2)
CYDY CytoDyn Inc
12/17/2020 6:09:13 PM
I agree - things are different and (3)
CYDY CytoDyn Inc
12/17/2020 4:15:54 PM
I thought the same thing a day or (1)
CYDY CytoDyn Inc
12/16/2020 7:06:50 PM
Oooppps....here is the article: htt (1)
CYDY CytoDyn Inc
12/16/2020 7:06:18 PM
This is a good article on NeuroAIDs (1)
CYDY CytoDyn Inc
12/16/2020 1:22:38 PM
Am I the only one that sees a simil (2)
CYDY CytoDyn Inc
12/13/2020 2:40:59 PM
Dividends: Love Nader or hate him, (1)
CYDY CytoDyn Inc
12/11/2020 10:21:14 PM
Thank you.
CYDY CytoDyn Inc
12/11/2020 10:03:02 PM
Dr Viro: I am genuinely curious wha
CYDY CytoDyn Inc
12/10/2020 10:05:29 PM
Thanks Chuckles, I appreciate your (1)
CYDY CytoDyn Inc
12/10/2020 8:58:21 PM
“ I couldn’t help but hear NP s (3)
CYDY CytoDyn Inc
12/09/2020 1:54:03 PM
Yup. As much as I appreciate the bu (3)
CYDY CytoDyn Inc
12/08/2020 10:07:58 AM
“ CYDY is quite undervalued” As (1)
CYDY CytoDyn Inc
12/07/2020 2:15:33 PM
"I’ve been trying to figure out h (2)
CYDY CytoDyn Inc
12/07/2020 10:55:43 AM
“ why all these lockdowns?!” Ri (1)
CYDY CytoDyn Inc
11/23/2020 11:45:09 AM
Thank you CT. Do you think they wil
CYDY CytoDyn Inc
11/23/2020 11:28:16 AM
“Same time span for DSMC review o
CYDY CytoDyn Inc
10/28/2020 5:13:35 PM
"A lot of science is more evolution (2)
CYDY CytoDyn Inc
10/28/2020 1:41:39 PM
One of the moments of the last conf (1)
CYDY CytoDyn Inc
10/28/2020 1:17:11 PM
Ironically here, leronlimab could h (1)
CYDY CytoDyn Inc
10/27/2020 11:36:28 AM
“Does CYDY HIV monotherapy mean n (2)
CYDY CytoDyn Inc
10/26/2020 3:29:45 PM
My apologies for not being clear. A
CYDY CytoDyn Inc
10/26/2020 12:11:50 PM
The US Covid deaths are now about 1
CYDY CytoDyn Inc
10/26/2020 12:00:51 PM
I agree - drastic times requires dr (3)
CYDY CytoDyn Inc
10/26/2020 11:53:55 AM
The FDA argument against EINDs was
CYDY CytoDyn Inc
10/21/2020 11:25:09 AM
That should be 25.6%..... can’t f
CYDY CytoDyn Inc
10/21/2020 11:23:11 AM
This is a great article that explai (3)
CYDY CytoDyn Inc
10/20/2020 11:33:09 AM
Challenge trials for vaccines will (1)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Harnessing AI in PR: Insights from Industry Leaders at IPRS
  • Peter Schiff's Perspective on Bitcoin's Recent Surge
  • Innovative Developments at Defense Metals Enhance Future
  • Celebrating Italian Wine Ambassadors at Vinitaly Academy
  • Defense Metals Advances Wicheeda Project with Strategic Plans
  • Dave Ramsey: Three Core Investments for Financial Stability
  • AMD's Bold AI Partnership: CEO Sees Massive Financial Gains Ahead
  • Duck Creek Technologies' Annual Summit Emphasizes Inclusion
  • Cryptocurrency Market Surge: A Deep Dive into Trends and Stakes
  • Stock Market Highlights: AMD, AppLovin, Trilogy Metals, Nike, Verizon
  • ONEOK Facility Incident Update: Safety Measures in Action
  • Exploring the Future Growth of the Green Ammonia Market
  • Cathie Wood's Latest Trading Moves: Heavy Investments Explained
  • Exploring MoonLake Immunotherapeutics: A Dive into Recent Investigations
  • Join the Investigation into MoonLake Immunotherapeutics Claims
  • GOFO Unveils State-of-the-Art Logistics Facility in New Jersey
  • AmgenNow Program Enhances Access to Repatha for Patients
  • Consumer Guardian Group Expands Support for Timeshare Owners
  • Empowering Investors: Join Legal Action Against Fly-E Group
  • Know Your Rights: Class Action Update for Charter Investors
  • KBR, Inc. Faces Securities Fraud Class Action Lawsuit
  • Shaquille O'Neal Delivers Joy in Hershey at Special Events
  • Grupo Simec Enhances Financial Transparency with Form 20-F Amendment
  • Trilogy Metals Celebrates Approval of Ambler Access Project
  • Dr. James A. Tompkins Rejoins Tompkins Solutions as Chairman
  • Vinitaly.USA 2025: Celebrating Italian Wine in Chicago
  • Unveiling the Surprising Stock Picks of Famous Investors
  • Discover How a $100 Investment in Charles Schwab Has Grown
  • Transforming $1000 into $16364 with F5 Stock Investment
  • Investors Unite: Join the Spirit Aviation Legal Challenge
  • GAIM.FUN's Innovative Funding to Transform Virtual Worlds
  • Eagle Pharmaceuticals Shares First Quarter Financial Overview
  • Verde AgriTech Unveils Major Rare Earth Discovery in Brazil
  • Fortinet Investors Urged to Act Amidst Class Action Lawsuit
  • Incredible Growth of First BanCorp: A Decade of Investment Success
  • Understanding the KinderCare Learning Companies Class Action
  • Mesoblast's Ryoncil Sales Surge with Impressive Growth
  • Join the Fight for Justice with Spirit Aviation Holdings, Inc.
  • Qualtrics' Bold Move to Transform Experience Management with Forsta
  • Mesoblast's Ryoncil® Achieves Remarkable Revenue Growth
  • Investing in Growth: An Insight into GMO’s DRES ETF
  • FLYE Investors Face Securities Fraud Lawsuit Opportunity
  • KBR, Inc. Shareholders Urged to Act on Class Action Case
  • Understanding the Class Action Against Jasper Therapeutics and JSPR
  • Fortinet, Inc. Class Action Update: Important Investor Insights
  • LuxUrban Securities Case: Key Allegations Dismissed by Court
  • AEG Europe Leads the Charge in Sustainable Power for UK Venues
  • Qualigen Therapeutics Strengthens Leadership with Key Appointments
  • Legal Counsel Alert for Unicycive Therapeutics Inc. Investors
  • Transforming $100 Into $670: The InterDigital Investment Journey
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site